Search research articles
Contact Us
Filters
Showing results (121-130 of 236) with videos related to
Page
of 24
Sort By:
Cell Metabolism
|
April 15, 2016
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
Navdeep S Chandel, Dania Avizonis, Colleen R Reczek, et al.
Carcinogenesis
|
July 27, 2021
Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome
Byuri Angela Cho, Neil M Iyengar, Xi Kathy Zhou, et al.
The Prostate
|
September 12, 2008
Insulin receptor expression by human prostate cancers
Michael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Endocrine-Related Cancer
|
September 28, 2011
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer
Carly Jade Dool, Haider Mashhedi, Mahvash Zakikhani, et al.
Clinical Genitourinary Cancer
|
January 29, 2019
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Michael Mark, Dirk Klingbiel, Ulrich Mey, et al.
Breast Cancer Research : BCR
|
October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi, Samuel Leung, Jennifer H Law, et al.
The Prostate
|
May 1, 2013
Exercise does not counteract the effects of a "westernized" diet on prostate cancer xenografts
Avi D Vandersluis, Natalie A Venier, Alexandra J Colquhoun, et al.
Cancer Research
|
November 8, 2014
Serine deprivation enhances antineoplastic activity of biguanides
Simon-Pierre Gravel, Laura Hulea, Nader Toban, et al.
CA: a Cancer Journal for Clinicians
|
June 18, 2010
Diabetes and cancer: a consensus report
Edward Giovannucci, David M Harlan, Michael C Archer, et al.
Journal of Cancer Epidemiology
|
June 25, 2015
Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast
Chelsea Catsburg, Marc J Gunter, Lesley Tinker, et al.
Page
of 24
Search research articles
Search
Showing results (121-130 of 236) with videos related to
Sort By:
Page
of 24
Cell Metabolism
|
April 15, 2016
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
Navdeep S Chandel, Dania Avizonis, Colleen R Reczek, et al.
Carcinogenesis
|
July 27, 2021
Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome
Byuri Angela Cho, Neil M Iyengar, Xi Kathy Zhou, et al.
The Prostate
|
September 12, 2008
Insulin receptor expression by human prostate cancers
Michael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Endocrine-Related Cancer
|
September 28, 2011
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer
Carly Jade Dool, Haider Mashhedi, Mahvash Zakikhani, et al.
Clinical Genitourinary Cancer
|
January 29, 2019
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
Michael Mark, Dirk Klingbiel, Ulrich Mey, et al.
Breast Cancer Research : BCR
|
October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi, Samuel Leung, Jennifer H Law, et al.
The Prostate
|
May 1, 2013
Exercise does not counteract the effects of a "westernized" diet on prostate cancer xenografts
Avi D Vandersluis, Natalie A Venier, Alexandra J Colquhoun, et al.
Cancer Research
|
November 8, 2014
Serine deprivation enhances antineoplastic activity of biguanides
Simon-Pierre Gravel, Laura Hulea, Nader Toban, et al.
CA: a Cancer Journal for Clinicians
|
June 18, 2010
Diabetes and cancer: a consensus report
Edward Giovannucci, David M Harlan, Michael C Archer, et al.
Journal of Cancer Epidemiology
|
June 25, 2015
Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast
Chelsea Catsburg, Marc J Gunter, Lesley Tinker, et al.
Page
of 24